Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain.
Rivero-Juarez A, Gutierrez-Valencia A, Castaño M, Merino D, Neukam K, Ríos-Villegas MJ, Lopez-Ruz MA, Jiménez-Aguilar P, Marquez M, Collado A, Gomez-Vidal A, Hernandez-Quero J, Tellez F, Fernandez-Fuertes E, Rivero A, López-Cortés LF; Group for the Study of Viral Hepatitis (HEPAVIR) of the Andalusian Society of Infectious Diseases (SAEI).
Rivero-Juarez A, et al.
Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2247-55. doi: 10.1007/s10096-015-2476-9. Epub 2015 Sep 5.
Eur J Clin Microbiol Infect Dis. 2015.
PMID: 26342330
Free PMC article.
The implementation of hepatitis C (HCV) direct-acting antiviral drugs is prioritized in several populations in which its application provides the most immediate and impactful benefit. ...A total of 13,506 HIV-infected patients were included in the study. Of them, 25 …
The implementation of hepatitis C (HCV) direct-acting antiviral drugs is prioritized in several populations in which its application …